Obtaining the Minimum Lethal Dose against Fasciola hepatica in Vitro Using Plant Extract Hexanes with Fasciolicide Activity and Toxicity Evaluation on CD1 Male Mice

Stephanie Ibarra-Moreno, Froylan Ibarra-Velarde, Jose Guillermo Avila-Acevedo

Depto. De Parasitología. Facultad de Medicina Veterinaria. Y Zootecnia. UNAM. Ciudad Universitaria, 04510 México D.F., México;.
Lab. De Fitoquímica. UBIPRO. Facultad de Estudios Superiores Iztacala. UNAM. Avenida de los Barrios S/N Tlalnepantla de Baz, Edo. De México..

DOI: 10.4236/ajps.2012.37106                

Abstract

Fascioliasis is a parasitic disease of worldwide distribution affecting mainly cattle and sheep. Its importance lies in the economic losses it produces in the livestock industry. Its control is carried out by using a chemical fasciolicide showing resistance problems and environmental contamination. Looking for an alternative control for this disease the present study was aimed at determining the hexane anti-Fasciola hepatica in the in vitro effect of some plant extracts and the minimum lethal dose of the mentioned extracts. All selected plants were tested in vitro at concentrations of 500, 250, 125 and 50 mg/L):Achilleamillefolium (plumajillo), Artemisiaabsinthium (wormwood), Artemisia mexicana (estafiate), Castelatortuousa (chaparroamargo), Chenopodiumgraveolens (epazote de zorrillo), Gymnospermaglutinosum (popote) Justicia spicigera (muicle), Limpia critridora (cedron), Lippiagraveolens (oregano), Menthapiperita (Mint), Populus alba (alamo) and Thymusvulgaris (thyme). Subsequently proceeded to perform a toxicity study with these fractions in CD1 male mice 10-13 weeks of age, forming groups of 3-5 animals they were administered a single oral dose being (5 mg/kg, 50 mg/kg, 500 mg/kg, 2500 mg/kg and 5000 mg/kg) and were kept under observation 20 days, later were sacrificed and a kidney and liver histology was performed, finding the safety of the extracts. To perform the toxicity study with these fractions, groups of five CD1 male-mice were formed, they were treated with oral doses of 5, 50, 500, 2500 and 5000 mg/kg, administered with a cannule. All mice were kept under observation for 20 days. Finally they were sacrificed to perform histology of the kidney and liver in search of possible side effects. Results show that none of the extracts exhibited that fasciolocide activity for mice CD1 even at the highest dose thereforefinding the safety of the extracts.

Keywords

Fasciola hepatica; Plant Extracts; In Vitro; Minimum Lethal Dose; Toxicity

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Basso y Nilda “Bases de la Parasitología Veterinaria”, Ed., Hemisferio Sur, México, 1992, pp.157.
[2]	F. Ibarra, J. Figueroa and H. Quiroz, “Parasitología Veterinaria Volumen II Helmintos” U.N.A.M., México D.F. 2011.
[3]	Tay and Velasco, “Parasitología Médica”. Editorial Mendez, Séptima edición, México D.F., 2002
[4]	Nari and C. Fiel, “Enfermedades parasitarias de importancia económica en bovinos: Bases epidemiológicas para su prevención y control”. Editorial Hemisferio Sur México D.F., 1988.
[5]	F. Froylán, N. Montenegro, Y. Vera, R. Castillo, A. Hernández, P. Ochoa., “Eficacia comparativa de un fasciolocida experimental, triclabendazol y closantel en bovinos infectados en forma natural con Fasciolahepatica”. Veterinaria México, Vol. 33 No.3, 2002, pp.237 – 245.
[6]	F. Froylán, N. Montenegro, J. Flores, A. Hernández, R. Castillo., “Evaluación de cuatro vehículos para formular un fasciolocida experimental”. Veterinaria México, Vol. 1, No. 001, 2000, pp.1-7.
[7]	FHM. Borgsteede, “Gastrointestinal helminthiasis: Anthelmintic resistance and how to prevent and control”. SymposiumParasitology International 47, 1998, (Suppl): 23-48.
[8]	J. Rzedowski, “Vegetación de México”, Ed., LI-MUSA, México, 1978, pp. 472.
[9]	J.Díaz, J. L “índice y sinonimias de las plantas medicinales de México. Instituto Mexicano para el Estudio de las Plantas Medicinales”. Instituto de Investigaciones Biomédicas. UNAM, México D.F.,1976.
[10]	M. Columba and E. Castillo, “Plantas medicinales utilizadas en el estado de Morelos”. Ed., Universidad Autónoma del estado de Morelos Conabio, Mexico, 2007, pp. 405.
[11]	[11] G. Dominguez, M. ángel and B. Aguilar,) “El mercado de plantas medicinales en México situación actual y perspectivas de desarrollo” 2004. http://www.herbotecnia.com.ar/c-public-003.html
[12]	J. Vercruysse, P. Holdsworth,T. Letonia, D. Barth, G. Conder, K. Hamamoto, K.,“Internationalharmonisation of Anthelmintic Efficacy Guidelines”. Veterinary Parasitology,Vol.96 No.6, 2001, pp.171-193.
[13]	N. Rivera, F. Ibarra, A. Zepeda, T. Fortoul, A. Her?nandez, R. Castillo. “Tegumental surface changes in adult Fasciola hepatica following treatment in vitro and in vivo with an experimental fasciolicide”. Parasitol Res 2004; 93:283-286.
[14]	F. Ibarra and D.C. Jenkins “An in vitro screen for new fasciolicidal agents”. Z Parasitenkd, Vol. 70, 1984, pp. 655–661. http://www.springerlink.com/content/h2321x15g416t701/fulltext.pdf
[15]	Ibarra-Moreno S., Ibarra F. and Avila J.G., “In vitro evaluation of fasciolicide activity with hexane, metanol and ethyl acetate with extracts processed and obtained from some Mexican plants used in traditional medicine based on ethno botanical studies” American Journal of Plant Sciences (AJPS). 2012
[16]	T. Hernández, M. Canales, J.G. Avila, A. Duran, J. Caballero, A. Romo de Vivar, R. Lira, “Ethnobotany and antibacterialactivity of someplantsused in traditional medicine of Zapotitlán de las Salinas, Puebla (México)”. Journal of Ethnopharmacology.Vol. 88,No.2, 2003, pp. 181-188.
[17]	M.Pascual, K. Slowing, E. Carretero, D. Sánchez Mata, A. Villar, “Lippia: traditional uses, chemistry and pharmacology”, Journal of Ethnopharmacology, Vol. 76, No.3, 2011, pp. 201-214.
[18]	D. Bahuaud, C. Martínez-Ortiz de Montellano, S.Chauveau, F. Prevot, F. Torres-Acosta, I. Fouraste, H. Hoste. “Effects of four tanniferous plant extracts on the in vitro exsheathment of third-stage larvae of parasitic nematodes”.Parasitology Vol.132, No. 6, 2005, pp. 545-554.
[19]	M. Sachana, A.J. Hargreaves “Toxicological testing: in vitro and in vivo models. En: Veterinary Toxicology: Basic and Clinical Principles” (Gupta RC, ed.) Academic Press, New York, 2007. http://www.ropana.cl/Toxivet/Relacion%20Dosis-Respuesta.htm
[20]	Klaaseen, J. Watkins III “Fundamentos de toxicología” .Ed. Mc Graw Hill Interamericana, México, 2005, pp.536.
[21]	Lagarto, J. Tillán, R. Vega, Y. Cabera “Toxicidad aguda oral de extractos hidroalcohólicos de plantas medicinales” Revista Cubana de Plantas Medicinales. Vol.1, No.4, 1999, pp. 8-26.
[22]	M. Rivera, L. Macías, M. Tinoco, I. García, I. Ruíz, “Toxicidad aguda en rata y ratón de la casiopeína (gli)” 2do. Congreso Nacional de Química Médica (CNQM) 2000.